1Cell.Ai Inc.

Home
India
Mumbai
1Cell.Ai Inc.

1Cell.Ai is AI-powered precision oncology—revolutionizing liquid biopsy, single-cell multiomics & digital pathology.

One Cell DiagnosticsTM Inc., a genomics-based Precision Oncology company, based in Silicon Valley, CA and with India operations. We provide comprehensive genomic solutions for better cancer management leveraging cutting-edge Next-Generation Sequencing technology in combination with strong bioinformatics, AI and ML technology for Multi-omics Biomarker.

05/06/2026

𝟓 𝘸𝘦𝘦𝘬𝘴. 𝟒 𝘳𝘦𝘱𝘰𝘳𝘵𝘴. 𝟑 𝘭𝘢𝘣𝘴. 𝘚𝘵𝘪𝘭𝘭 𝘯𝘰 𝘤𝘭𝘦𝘢𝘳 𝘢𝘯𝘴𝘸𝘦𝘳.

That's the reality thousands of endometrial cancer patients face, while every delayed decision is a delayed chance at survival.

Introducing 𝙊𝙣𝙘𝙤𝙄𝙣𝙙𝙭® 360° 𝙀𝙣𝙙𝙤𝙢𝙚𝙩𝙧𝙞𝙪𝙢 by 1Cell.Ai Inc.

The first upfront, integrated molecular test built for endometrial cancer.
One test. One unified report. Integrated NGS + IHC. Biology-driven interpretation with WHO-aligned treatment guidance delivered in just 10-12 days.

No fragmentation. No delays. Just clarity when it matters most.
"Because smarter decisions start with better diagnostics".

Learn more about Oncolndx® 360° Endometrium- https://1cell.ai/in/products/oncoindx-360/ See less

14/03/2026

Can CSF-based NGS change patient outcomes?

Dr Bhuvan Chugh - Consultant Medical Oncologist, New Delhi discusses how CSF based NGS tests helped detect actionable mutations in a patient with EGFR-mutant NSCLC & leptomeningeal disease.

This case highlights the critical role of NGS using a multi-modal approach including circulating tumor DNA (ctDNA) & single circulating tumor cell (sCTC) DNA from CSF.

Read the publication here:
https://zurl.co/vrfQj

08/03/2026

Celebrating the women who lead, inspire, and make a difference every day.
Your strength and dedication shape a better future.

Happy Women’s Day! 🌸

06/03/2026

Dr. Thushara Thamban, Scientific Writer at 1Cell.AI, explains how downstream effector mutations may signal resistance to tyrosine kinase inhibitors in EGFR-mutated lung cancer patients.

Watch the video to know how 1Cell.Ai is enabling personalised cancer care.

02/03/2026

May this Holi fill your life with bright colours, new beginnings, and beautiful memories.

Celebrate the joy of colours. Happy Holi!

10/02/2026

🔬 Integrated Molecular Tumor Board | 11th February 2026
(7:00–8:00 PM IST)

Join us for an insightful IMTB session where leading oncologists and molecular experts discuss real-world cancer cases through a precision oncology lens.

Chairperson
Dr. Bharat Bhosale
Founder & Director, BB Precision Oncocare Centre
Visiting Medical & Precision Oncologist, Bombay Hospital

🧭 Agenda

Host
Dr. Rajeev Vikram
Genome Scientist, 1Cell.Ai

Case 1
Advanced Germ Cell Tumor: A Multimodal Treatment Approach
Dr. Jyoti Anand
Senior Consultant, Medical Oncology, Fortis Hospital, Greater Noida
Dr. Moushumi Suryavanshi
Senior Consultant & Head, Molecular Biology & Cytogenetics, Amrita Hospital, Faridabad

Case 2
Metachronous Breast and Lung Cancer with a Rare EGFR Exon 19 Mutation: A Case Study
Dr. Ananth Pai
Professor, Department of Medical Oncology, Kasturba Medical College, Manipal
Dr. Vidya Jha
Deputy Medical Superintendent & Chief, Advanced Centre for Clinical Genomics,
Amrita Institute of Medical Sciences, Kochi

Case 3
Plasma Genotyping Reveals STK11-Driven Immunotherapy Resistance in NSCLC
Dr. Asif Shaikh
Consultant Medical Oncologist, AVRON Multi-Speciality Hospitals, Ahmedabad
Dr. Vijayalakshmi Ramshankar
Professor & HoD, Cancer Biology & Molecular Diagnostics,
Cancer Institute (WIA), Adyar, Chennai

Q&A Session

👉 Scan the QR code on the poster to join the live webinar
👉 Learn more at 1Cell. Ai

Click the link to register for the webinar: https://zurl.co/p4kdGhttps://zurl.co/YmXah

05/02/2026

1Cell.Ai participated in the 13th International Patient Safety Conference (IPSC 2026) in Hyderabad. The event brought together healthcare leaders for impactful conversations on patient safety, care quality, and innovation highlighting the role of AI, new advances, and holistic approaches in cancer care.

04/02/2026

1Cell.Ai participated in the recently held 7th Annual Conference of the Immuno-Oncology Society of India (I-OSICON 2026) at Chennai. The event was marked by exciting knowledge exchange; Dr Gowhar Shafi - Chief Medical Geneticist, 1Cell.Ai was a faculty in the panel on "Multidisciplinary Board On Precision Oncology" moderated by Dr Jyoti Bajpai.

.ai

Address

701, Sigma Building, Hiranandani Gardens, Powai
Mumbai
400076

Website

https://1cell.ai/

Alerts

Be the first to know and let us send you an email when 1Cell.Ai Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Want your business to be the top-listed Engineering Company in Mumbai?